GlassScriptPhysician profile
John Doromal Jacob
NPI 1801182662
$12,347.09
in general payments reported to CMS, 2019-2025
10 companies · $83.48 in 2025
The $83.48 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.36 · 2020: $14.99 · 2021: $22.16 · 2022: $756 · 2023: $6,631 · 2024: $4,826 · 2025: $83.48.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $9,800 · Travel and Lodging: $957 · Food and Beverage: $783.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $9,800.00 |
| Travel and Lodging | $957.40 |
| Food and Beverage | $783.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $11,553.09 | 2022-2024 | Ion, Davinci Xi, Da Vinci Surgical System |
| Astrazeneca Pharmaceuticals LP | $305.59 | 2019-2022 | |
| Galvanize Therapeutics, INC | $171.97 | 2024 | Aliya System |
| Atricure, INC. | $92.18 | 2022-2023 | |
| Depuy Synthes Sales INC. | $59.95 | 2023-2024 | Matrixrib |
| Cook Medical LLC | $55.34 | 2025 | Wayne |
| Ethicon US, LLC | $49.79 | 2023-2024 | Echelon Endopath, Echelon; Endopath, Enseal |
| Pacira Pharmaceuticals Incorporated | $28.14 | 2025 | Exparel |
| Paladin Technology Solutions | $17.17 | 2024 | |
| Urovant Sciences INC | $13.87 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Jacob listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.